Making translational value:Identifying 'good targets' for clinical research on gene editing and induced pluripotent stem cell technologies

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	100131
Number of pages	8
Journal	SSM - Qualitative Research in Health
Volume	2
Early online date	14 Jul 2022
DOIs	https://doi.org/10.1016/j.ssmqr.2022.100131
Publication status	E-pub ahead of print - 14 Jul 2022

Access to Document

@article{abe0527c0efc4ca7b8eb24a320c6de70,

title = "Making translational value:Identifying 'good targets' for clinical research on gene editing and induced pluripotent stem cell technologies",

author = "Michael Morrison and Bartlett, {Andrew James}",

note = "{\textcopyright} 2022 The Authors. Published by Elsevier Ltd. ",

year = "2022",

month = jul,

day = "14",

doi = "10.1016/j.ssmqr.2022.100131",

language = "English",

volume = "2",

journal = "SSM - Qualitative Research in Health",

issn = "2667-3215",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Making translational value:Identifying 'good targets' for clinical research on gene editing and induced pluripotent stem cell technologies

AU - Morrison, Michael

AU - Bartlett, Andrew James

PY - 2022/7/14

Y1 - 2022/7/14

U2 - 10.1016/j.ssmqr.2022.100131

DO - 10.1016/j.ssmqr.2022.100131

M3 - Article

SN - 2667-3215

VL - 2

JO - SSM - Qualitative Research in Health

JF - SSM - Qualitative Research in Health

M1 - 100131

ER -